Publications by authors named "Alessandro Parra"

Claim this Profile
G
Genomic profiling of a collection of patient-derived xenografts and cell lines identified ixabepilone as an active drug against chemo-resistant osteosarcoma.
Maria Cristina Manara, Francesca Bruzzese, Laura Formentini, Lorena Landuzzi, Laura Pazzaglia, Alessandro Parra

J Exp Clin Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells.
Caterina Mancarella, Veronica Giusti, Giulia Caldoni, Maria Antonella Laginestra, Alessandro Parra

Cancer Gene Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.
Michela Pasello, Anna Maria Giudice, Camilla Cristalli, Maria Cristina Manara, Caterina Mancarella, Alessandro Parra

Cell Oncol (Dordr)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.
Michela Pasello, Anna Maria Giudice, Camilla Cristalli, Maria Cristina Manara, Caterina Mancarella, Alessandro Parra

Cell Oncol (Dordr)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma.
Marianna Carrabotta, Maria Antonella Laginestra, Giorgio Durante, Caterina Mancarella, Lorena Landuzzi, Alessandro Parra

Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma.
Marika Sciandra, Alessandra De Feo, Alessandro Parra, Lorena Landuzzi, Pier-Luigi Lollini

J Cell Commun Signal· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis.
Caterina Mancarella, Giulia Caldoni, Irene Ribolsi, Alessandro Parra, Maria Cristina Manara

Front Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group.
Dominga Racanelli, Monica Brenca, Davide Baldazzi, Frauke Goeman, Beatrice Casini, Alessandro Parra

Front Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group.
Dominga Racanelli, Monica Brenca, Davide Baldazzi, Frauke Goeman, Beatrice Casini, Alessandro Parra

Front Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations.
Patrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, Alberto Righi, Giordano Nicoletti, Alessandro Parra

Sci Rep· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Features of Heparan Sulfate from Multiple Osteochondromas and Chondrosarcomas.
Noemi Veraldi, Alessandro Parra, Elena Urso, Cesare Cosentino, Manuela Locatelli

Molecules· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD99 polymorphisms significantly influence the probability to develop Ewing sarcoma in earlier age and patient disease progression.
Marcella Martinelli, Alessandro Parra, Luca Scapoli, Paola De Sanctis, Valentina Chiadini

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a quantitative PCR-high-resolution melting protocol for simultaneous screening of COL1A1 and COL1A2 point mutations and large rearrangements: application for diagnosis of osteogenesis imperfecta.
Filomena Valentina Gentile, Monia Zuntini, Alessandro Parra, Luca Battistelli, Martina Pandolfi

Hum Mutat· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin-like heparan sulfate from rabbit cartilage.
Alessandro Parra, Noemi Veraldi, Manuela Locatelli, Milena Fini, Lucia Martini

Glycobiology· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-phenotype correlation study in 529 patients with multiple hereditary exostoses: identification of "protective" and "risk" factors.
Elena Pedrini, Ivy Jennes, Morena Tremosini, Annamaria Milanesi, Marina Mordenti, Alessandro Parra

J Bone Joint Surg Am· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas.
Ivy Jennes, Mark M Entius, Els Van Hul, Alessandro Parra, Luca Sangiorgi

J Mol Diagn· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis